FUJIFILM launches Interventional Cardiology Business to combat rising heart disease in MEA

UAE—FUJIFILM Middle East FZE has unveiled its innovative Interventional Cardiology Business Line across the Middle East and Africa region, timing the announcement with the upcoming WHX Dubai 2026 (formerly Arab Health).

The prestigious healthcare exhibition will run from February 9 to 12, 2026, at the Dubai Exhibition Center in Expo City.

Strategic partnership to expand cardiac care access

The company will officially launch this new business line at its booth during the event, representing a pivotal moment in FUJIFILM’s ongoing efforts to advance healthcare delivery and make quality cardiac care more accessible throughout the region.

To bring this vision to life, FUJIFILM Middle East has formed a strategic alliance with Innvolution Healthcare, a leading provider specializing in precision diagnostic solutions and personalized cardiovascular disease treatment.

This collaboration aims to broaden access to world-class interventional cardiology technologies across Middle Eastern and African markets.

The partnership will equip hospitals and healthcare providers with cutting-edge, high-quality interventional cardiac solutions designed to meet the growing demand for advanced cardiovascular care.

Comprehensive portfolio of advanced cardiac solutions

Through this partnership with Innvolution Healthcare, FUJIFILM Middle East will distribute an extensive range of interventional cardiology products.

The portfolio encompasses cardiac catheterization laboratories (cathlabs and angiography systems), Optical Coherence Tomography (OCT) systems, balloon catheters, and drug-eluting stents, alongside various interventional and cardiac accessories.

These precision-engineered products support cardiologists in delivering accurate diagnoses while enabling personalized treatment plans that lead to improved clinical outcomes for patients.

FUJIFILM will integrate these offerings with its established cardiovascular IT solutions, cardiac CT scanners, and ultrasound diagnostic devices already recognized throughout the region.

This comprehensive approach ensures optimal care for the rapidly expanding population of patients battling cardiovascular conditions.

Addressing a critical regional health challenge

Shin Tagawa, Managing Director of FUJIFILM Middle East, emphasized that launching the Interventional Cardiology Business represents a major advancement in the company’s mission to drive healthcare innovation.

He highlighted that cardiovascular diseases pose a significant and escalating health challenge across the region.

The statistics paint a sobering picture: more than 1.4 million people die from cardiovascular diseases annually in the Middle East and North Africa alone, marking a nearly 48% increase over the past three decades.

Africa faces similarly dire circumstances, with over 1 million people succumbing to cardiovascular disease each year, establishing it as one of the continent’s primary causes of death.

Tagawa explained that these alarming figures demonstrate the urgent need for enhanced diagnostic capabilities and affordable treatment options.

The collaboration with Innvolution Healthcare directly addresses this critical gap by delivering advanced and reliable interventional cardiology technologies to clinicians and patients who need them most urgently.

Commitment to elevating cardiac care standards

Gaurav Agarwal, Managing Director of Innvolution Healthcare, expressed pride in partnering with FUJIFILM Middle East to expand access to premier interventional cardiology solutions throughout Middle Eastern and African markets.

He stated that their joint efforts will elevate cardiac care standards and support better patient outcomes across the region.

Agarwal noted that this collaboration reinforces their long-term commitment to the healthcare sector by delivering cutting-edge medical imaging, interventional solutions, and comprehensive clinical support to healthcare professionals who serve diverse communities.

Market-leading technologies for better outcomes

FUJIFILM Middle East’s Interventional Cardiology Business features several industry-leading solutions.

The portfolio includes a compact and affordable floor-mounted, single-plane interventional imaging system that elevates imaging precision while providing flexible operating space and the deepest angles available.

This system improves patient care by streamlining the workflow for cardiovascular, peripheral vascular, and neurovascular diagnostic and interventional procedures.

It comes equipped with high-performance AI technology that enhances the visibility of stent images, complemented by advanced software for precise stent planning.

The offering also features high-resolution intravascular imaging that empowers cardiologists with exceptional clarity and precision during interventional procedures.

These OCT systems enhance visualization of vascular anatomy and lesion morphology, supporting accurate diagnoses, optimal treatment planning, and improved patient outcomes.

Additionally, the portfolio includes the Everolimus drug-eluting stent, considered the highest grade in its class.

This innovative stent achieves an industry-leading strut thickness of just 60 microns. Its proprietary wave-shaped design strikes a careful balance between ease of insertion and structural strength.

Reducing connector components improves blood flow at coronary bifurcations, providing enhanced side-branch access, superior endothelial coverage, and optimal conformity to angulated vessels.

Join the official launch

Healthcare professionals and industry stakeholders can attend the official launch of Interventional Cardiology Solutions at WHX Dubai 2026.

The event will take place at the FUJIFILM Middle East booth #N21.G50 in the North Hall on February 9, 2026.